1-(5-tert-butyl-2-methyl-2h-pyrazol-3-yl)-3-(4-chloro-phenyl)-urea

1-(5-tert-butyl‑2-methyl‑2H-pyrazol‑3‑yl)-3-(4-chloro‑phenyl)urea is a synthetic small molecule belonging to the phenylureas and pyrazoles chemical classes. It acts as an inhibitor of mitogen‐activated protein kinase (MAPK), specifically targeting mitogen‐activated protein kinase 14 (MAPK14, also known as p38α MAP kinase). The compound has been studied in biochemical assays for its inhibitory activity but is not approved for clinical use and remains experimental. There are no known approved indications or marketed formulations[1][3][6].

Other names

1-(5-Tert-butyl–2-methyl–2H-pyrazol–3–yl)–3–(4-chlorophenyl)urea3-(3-tert-butyl–1-methylpyrazol–5‑yl)‑1‑(4‑chlorophenyl)urea